NCT05344690View on ClinicalTrials.gov

SLMAP and EPO Genetic Polymorphism in Diabetic Retinopathy

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

May 20, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

June 30, 2023

Conditions
Diabetic Retinopathy
Interventions
GENETIC

SLMAP and EPO genetic polymorphism

Presence of EPO gene SNP rs551238 and SLMAP rs17058639 gene polymorphisms

Trial Locations (1)

Unknown

Ain Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER